Point of Care STI Testing
Recruiting
N/A
Interventional Study
Point of Care STI Testing
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 16 – 24
- Sex
- Any
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 6,460 (estimated)
- Sponsor
- Icahn School of Medicine at Mount Sinai · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The proposed research hypothesizes that point-of-care testing (POCT) for sexually transmitted infections (STIs) gonorrhea and chlamydia will be a feasible, acceptable, and appropriate implementation strategy for improving HIV testing and Pre-exposure prophylaxis (PrEP) delivery in youth, by increasing opportunities for clinician-patient counseling, decreasing loss to follow up, and allowing for sa…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
\- Patients age 16-24 years receiving POCT or lab-based GC/CT testing
Exclusion Criteria:
\- Patients with known HIV or active PrEP prescriptions.
Contacts